Tag: AMI Pharm

AMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus

SEOUL, South Korea, Aug. 11, 2025 /PRNewswire/ -- AMI Pharm, a biotechnology company focused on aesthetic and therapeutic innovations, announced today that its lead candidate,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsAMI Pharm

Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease

Iron Age Nutrition Announces Launch of “Sour Apple Crush” Flavor in Total Hydrate Electrolyte Line

UP Fintech Investor News: If You Have Suffered Losses in UP Fintech Holding Limited (NASDAQ: TIGR), You Are Encouraged to Contact The Rosen Law...

Tag: AMI Pharm

AMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us